The incidence of tumor recurrence was significantly suppressed in tumor-bearing mice treated with the HIF-1 inhibitor, YC-1, and by inhibiting EMT, suggesting a critical role of HIF-1 in tumor repopulation after radiation therapy [6]. Here, HIF1A is linked to neoplasm.